437 related articles for article (PubMed ID: 18606164)
1. Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies.
Lidqvist M; Nilsson O; Holmgren J; Hall C; Fermér C
J Immunol Methods; 2008 Sep; 337(2):88-96. PubMed ID: 18606164
[TBL] [Abstract][Full Text] [Related]
2. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859
[TBL] [Abstract][Full Text] [Related]
3. Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.
Donà MG; Giorgi C; Accardi L
BMC Cancer; 2007 Jan; 7():25. PubMed ID: 17266749
[TBL] [Abstract][Full Text] [Related]
4. The molecular specificity of linear B-epitopes in the E7 open reading frame protein of human papillomavirus 16 defined by monoclonal antibodies.
Tindle RW; Zhou WD; Saul A; Frazer IH
Pept Res; 1990; 3(4):162-6. PubMed ID: 1724617
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
Bolhassani A; Zahedifard F; Taghikhani M; Rafati S
Vaccine; 2008 Jun; 26(26):3362-70. PubMed ID: 18471945
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.
Smahel M; Poláková I; Pokorná D; Ludvíková V; Dusková M; Vlasák J
Int J Oncol; 2008 Jul; 33(1):93-101. PubMed ID: 18575754
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour.
Herd KA; Harvey T; Khromykh AA; Tindle RW
Virology; 2004 Feb; 319(2):237-48. PubMed ID: 14980484
[TBL] [Abstract][Full Text] [Related]
8. Platelet integrin alpha2 I-domain specific antibodies produced via domain specific DNA vaccination combined with variable gene phage display.
Hughes DL; Stafford P; Hamaia SW; Harmer lJ; Schoolmeester A; Deckmyn H; Farndale RW; Ouwehand WH; Watkins NA
Thromb Haemost; 2005 Dec; 94(6):1318-26. PubMed ID: 16411412
[TBL] [Abstract][Full Text] [Related]
9. [Screening and identification of mimic epitopes of monoclonal antibodies against hantaan virus using phage display technique].
Wang CJ; Tang JQ; Tao KH; Li XF; Bai W; Guo HB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):429-32. PubMed ID: 15207087
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 E7 peptide(38-61) linked with an immunoglobulin G fragment provides protective immunity in mice.
Qin Y; Wang XH; Cui HL; Cheung YK; Hu MH; Zhu SG; Xie Y
Gynecol Oncol; 2005 Feb; 96(2):475-83. PubMed ID: 15661238
[TBL] [Abstract][Full Text] [Related]
11. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope.
Kanduc D; Fanizzi FP; Lucchese G; Stevanovic S; Sinha AA; Mittelman A
Peptides; 2004 Feb; 25(2):243-50. PubMed ID: 15063005
[TBL] [Abstract][Full Text] [Related]
12. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M
J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328
[TBL] [Abstract][Full Text] [Related]
13. A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors.
Wick DA; Webb JR
Vaccine; 2011 Oct; 29(44):7857-66. PubMed ID: 21816200
[TBL] [Abstract][Full Text] [Related]
14. Characterization of BoHV-1 gE envelope glycoprotein mimotopes obtained by phage display.
Lehmann D; Sodoyer R; Leterme S
Vet Microbiol; 2004 Nov; 104(1-2):1-17. PubMed ID: 15530735
[TBL] [Abstract][Full Text] [Related]
15. Identification of epitopes of trichosanthin by phage peptide library.
Zhu Z; Ming Y; Sun B
Biochem Biophys Res Commun; 2001 Apr; 282(4):921-7. PubMed ID: 11352639
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
Brulet JM; Maudoux F; Thomas S; Thielemans K; Burny A; Leo O; Bex F; Hallez S
Eur J Immunol; 2007 Feb; 37(2):376-84. PubMed ID: 17274002
[TBL] [Abstract][Full Text] [Related]
18. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide (aa 44-60).
Pokorna D; Cerovska N; Smahel M; Moravec T; Ludvikova V; Mackova J; Synkova H; Duskova M; Hozak P; Veleminsky J
Oncol Rep; 2005 Oct; 14(4):1045-53. PubMed ID: 16142370
[TBL] [Abstract][Full Text] [Related]
20. Identification of B-epitopes in the human papillomavirus 18 E7 open reading frame protein.
Selvey LA; Tindle RW; Geysen HM; Haller CJ; Smith JA; Frazer IH
J Immunol; 1990 Nov; 145(9):3105-10. PubMed ID: 1698872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
